Hargreaves Lansdown, a London-listed retail-investment platform, revealed a decrease in pretax profit for the first half of its fiscal year, citing one-off costs associated with restructuring. Despite a rise in revenue, the company cautioned that it anticipates a challenging environment to persist into fiscal 2024.

Financial Performance Highlights

  • Pretax Profit: Reported at 182.5 million pounds, down from GBP197.6 million in the same period last year.
  • Exceptional Items: Including an impairment charge of GBP14.4 million and GBP2.9 million in restructuring costs.
  • Adjusted Pretax Profit: Increased by 5% to GBP221.5 million.
  • Revenue: Rose to GBP368.2 million from GBP350 million.
  • New Business: Declined to GBP1 billion from GBP1.6 billion.
  • Total Assets Under Administration: Reached a record GBP142.2 billion, exceeding analyst estimates.

Dividend and Client Growth

  • Interim Dividend: Raised to 13.2 pence per share.
  • Client Growth: Added 20,000 new clients, totaling 1.82 million.

Future Outlook

Hargreaves Lansdown remains cautious about the economic landscape, expecting investor confidence to be impacted. The company anticipates revenue margin to align with guidance and shares performance to be influenced by dealing volumes.

At 0813 GMT, shares dropped by 5.5% to 752.2 pence.


Fortescue Reports Strong First-Half Performance

Rivian Automotive Inc. 2024 Performance Analysis

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Rising Inflation Causes Sharp Drop in Metal Producers
News

Rising Inflation Causes Sharp Drop in Metal Producers

Recent rise in inflation leads to a sharp decline in metal producers as market expects interest rate hike to combat infl...

Donald Trump Chooses Not to Testify for Second Time in New York Civil Fraud Trial
News

Donald Trump Chooses Not to Testify for Second Time in New York Civil Fraud Trial

Former President Donald Trump announces he will not testify for the second time in his New York civil fraud trial, expre...

DocuSign Defies Macro Pressures
News

DocuSign Defies Macro Pressures

DocuSign stock defies macro pressures with remarkable performance, beating expectations and improving outlook. CEO empha...

BridgeBio Pharma Inc. Announces $250 Million PIPE Equity Offering
News

BridgeBio Pharma Inc. Announces $250 Million PIPE Equity Offering

BridgeBio Pharma Inc. experiences 3.8% surge in stock price after announcing $250 million PIPE equity offering. The offe...